First patients enrolled at uhealth – university of miami in aclarion's pivotal clarity trial

Broomfield, colo., september 25, 2025 – prism mediawire (press release service – press release distribution) – aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, today announced that the uhealth – university of miami health system and the miller school of medicine enrolled its first two patients in the clarity (chronic low back pain randomized independent trial study) trial. the pivotal clarity study is designed to demonstrate nociscan's clinical and economic value in spine surgery.
ACON Ratings Summary
ACON Quant Ranking